<VariationArchive VariationID="8250" VariationName="NM_000020.3(ACVRL1):c.760_762del (p.Asp254del)" VariationType="Deletion" Accession="VCV000008250" Version="14" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2015-10-11" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23289" VariationID="8250">
      <GeneList>
        <Gene Symbol="ACVRL1" FullName="activin A receptor like type 1" GeneID="94" HGNC_ID="HGNC:175" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="51906944" stop="51923361" display_start="51906944" display_stop="51923361" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="52301201" stop="52317144" display_start="52301201" display_stop="52317144" Strand="+" />
          </Location>
          <OMIM>601284</OMIM>
          <Haploinsufficiency last_evaluated="2016-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ACVRL1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ACVRL1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000020.3(ACVRL1):c.760_762del (p.Asp254del)</Name>
      <CanonicalSPDI>NC_000012.12:51914570:ACGAC:AC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="51914571" stop="51914573" display_start="51914571" display_stop="51914573" variantLength="3" positionVCF="51914570" referenceAlleleVCF="CACG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="52308355" stop="52308357" display_start="52308355" display_stop="52308357" variantLength="3" positionVCF="52308354" referenceAlleleVCF="CACG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D254del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.52308357_52308359del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.52308357_52308359del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.51914573_51914575del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.51914573_51914575del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009549.1" sequenceAccession="NG_009549" sequenceVersion="1" change="g.12156_12158del">
            <Expression>NG_009549.1:g.12156_12158del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000020.3" sequenceAccession="NM_000020" sequenceVersion="3" change="c.760_762del" MANESelect="true">
            <Expression>NM_000020.3:c.760_762del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000011.2" sequenceAccession="NP_000011" sequenceVersion="2" change="p.Asp254del">
            <Expression>NP_000011.2:p.Asp254del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077401.2" sequenceAccession="NM_001077401" sequenceVersion="2" change="c.760_762del">
            <Expression>NM_001077401.2:c.760_762del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070869.1" sequenceAccession="NP_001070869" sequenceVersion="1" change="p.Asp254del">
            <Expression>NP_001070869.1:p.Asp254del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_543" sequenceAccession="LRG_543">
            <Expression>LRG_543:g.12156_12158del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000020.2" sequenceAccession="NM_000020" sequenceVersion="2" change="c.760_762delGAC">
            <Expression>NM_000020.2:c.760_762delGAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_543t1" sequenceAccession="LRG_543t1">
            <Expression>LRG_543t1:c.760_762del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA119399" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601284.0008" DB="OMIM" />
        <XRef Type="rs" ID="387906393" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000020.3(ACVRL1):c.760_762del (p.Asp254del) AND Telangiectasia, hereditary hemorrhagic, type 2" Accession="RCV000008735" Version="13">
        <ClassifiedConditionList TraitSetID="2259">
          <ClassifiedCondition DB="MedGen" ID="C1838163">Telangiectasia, hereditary hemorrhagic, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000020.3(ACVRL1):c.760_762del (p.Asp254del) AND Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia" Accession="RCV000008736" Version="10">
        <ClassifiedConditionList TraitSetID="2260">
          <ClassifiedCondition DB="MedGen" ID="C1832529">Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-08-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000020.3(ACVRL1):c.760_762del (p.Asp254del) AND not provided" Accession="RCV000755791" Version="17">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-04-27" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000020.3(ACVRL1):c.760_762del (p.Asp254del) AND Cardiovascular phenotype" Accession="RCV002390098" Version="9">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-13" NumberOfSubmissions="6" NumberOfSubmitters="5" DateCreated="2015-10-11" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11484689</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12114496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14684682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17384219</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21158752</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26387786</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32300199</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2260" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9054" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED</ElementValue>
                <XRef Type="Allelic variant" ID="601284.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601284.0008" DB="OMIM" />
                <XRef ID="600376" DB="OMIM" />
              </Name>
              <XRef ID="C1832529" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2259" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3671" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Telangiectasia, hereditary hemorrhagic, type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Telangiectasia, hereditary hemorrhagic, type 2</ElementValue>
                <XRef ID="MONDO:0010880" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT2</ElementValue>
                <XRef Type="MIM" ID="600376" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ORW2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9901" />
                <XRef ID="9901" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528531" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528884" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515716" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511258" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000241591" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512240" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C1838163" DB="MedGen" />
              <XRef ID="MONDO:0010880" DB="MONDO" />
              <XRef Type="MIM" ID="600376" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28944" SubmissionDate="2017-12-06" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601284.0008_TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2" title="ACVRL1, 3-BP DEL, 759GAC_TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2" />
        <ClinVarAccession Accession="SCV000028944" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-08-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with hereditary hemorrhagic telangiectasia-2 (HHT2; 600376), Trembath et al. (2001) identified a 3-bp deletion (del759-761) in exon 6 of the ACVRL1 gene, resulting in deletion of asp254. Three members had isolated HHT and 2 members had both HHT and pulmonary arterial hypertension, 1 of whom had pulmonary arteriovenous malformations.</Attribute>
              <Citation>
                <ID Source="PubMed">11484689</ID>
              </Citation>
              <XRef DB="OMIM" ID="600376" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACVRL1" />
          </GeneList>
          <Name>ACVRL1, 3-BP DEL, 759GAC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 759GAC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601284.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="28945" SubmissionDate="2017-12-06" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601284.0008_PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED" title="ACVRL1, 3-BP DEL, 759GAC_PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED" />
        <ClinVarAccession Accession="SCV000028945" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-08-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with hereditary hemorrhagic telangiectasia-2 (HHT2; 600376), Trembath et al. (2001) identified a 3-bp deletion (del759-761) in exon 6 of the ACVRL1 gene, resulting in deletion of asp254. Three members had isolated HHT and 2 members had both HHT and pulmonary arterial hypertension, 1 of whom had pulmonary arteriovenous malformations.</Attribute>
              <Citation>
                <ID Source="PubMed">11484689</ID>
              </Citation>
              <XRef DB="OMIM" ID="600376" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACVRL1" />
          </GeneList>
          <Name>ACVRL1, 3-BP DEL, 759GAC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 759GAC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601284.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1729488" SubmissionDate="2018-10-10" DateLastUpdated="2019-02-18" DateCreated="2019-02-18">
        <ClinVarSubmissionID localKey="164822|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000883363" DateUpdated="2019-02-18" DateCreated="2019-02-18" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="-" referenceAllele="ACG" start="52308355" stop="52308357" variantLength="3" />
          </Location>
          <OtherNameList>
            <Name>p.Asp254del</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="387906393" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000020.2:c.760_762delGAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4618058</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5057723" SubmissionDate="2022-10-31" DateLastUpdated="2023-03-04" DateCreated="2022-11-05">
        <ClinVarSubmissionID localKey="GDXSV:246172" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002588440" DateUpdated="2023-03-04" DateCreated="2022-11-05" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11484689, 26387786, 32300199, 16611099, 17384219)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACVRL1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:655070</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000020.2:c.760_762del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_137_20221031152118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6130630" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4906677|MedGen:C1838163" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003440533" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11484689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32300199</ID>
          </Citation>
          <Comment>This variant, c.760_762del, results in the deletion of 1 amino acid(s) of the ACVRL1 protein (p.Asp254del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with clinical features of hereditary hemorrhagic telangiectasia (PMID: 11484689, 32300199; Invitae). ClinVar contains an entry for this variant (Variation ID: 8250). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACVRL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.52308355_52308357del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1838163" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5158152" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a6552|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002675267" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11484689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12114496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14684682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17384219</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21158752</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26387786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32300199</ID>
          </Citation>
          <Comment>The c.760_762delGAC variant (also known as p.D254del) is located in coding exon 5 of the ACVRL1 gene. This variant results from an in-frame deletion of GAC between nucleotide positions 760 and 762. This results in the deletion of an aspartic acid residue at codon 254. In one study, this variant was detected in one HHT family and was found to segregate with disease (Trembath RC, et al. N. Engl. J. Med. 2001 Aug; 345(5):325-34). In addition, this variant was reported in an individual with epistaxis, telangiectasias, a hepatic ateriovenous malformation, and a family history of HHT (McDonald J, et al. Clin. Genet. 2011 Apr; 79(4):335-44). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACVRL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000020.2:c.760_762delGAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1729488" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5158152" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28945" TraitType="Disease" MappingType="Name" MappingValue="PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED" MappingRef="Alternate">
        <MedGen CUI="C1832529" Name="Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6130630" TraitType="Disease" MappingType="XRef" MappingValue="C1838163" MappingRef="MedGen">
        <MedGen CUI="C1838163" Name="Telangiectasia, hereditary hemorrhagic, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28944" TraitType="Disease" MappingType="Name" MappingValue="TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1838163" Name="Telangiectasia, hereditary hemorrhagic, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5057723" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

